Sir,
We would like to clarify the results in ‘Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer’ as a reply to Huddart et al's Letter to the Editor.
In some agreement to Huddart et al's results, our study showed no influence of chemotherapy or any other treatment type on BMI compared to our healthy control material (Controls). Our results from the multivariate regression analysis indicated that in survivors of testicular cancer (TCSs), chemotherapy had an impact on the annual BMI increase independent of age and that the surgery group displayed no significant annual BMI increase (Nord et al, 2003). However, it only explained 8% of our observations as compared to the normal population, thus indicating a multifactorial background for the annual BMI increase. In Huddart et al's publication, the comparison to an age-matched cohort from the normal male population is lacking (Huddart et al, 2003). This is important as we, indeed, did not find significant BMI increase comparing the surgery group with the chemotherapy group. We admit that it is a weakness in our study that so few other explanatory factors were included in the regression analysis such as gonadal hormones, smoking, exercise and eating habits, which all have well-documented influences on BMI.
We still conclude that young TCSs, especially after chemotherapy, are at risk of excessive annual BMI increase as compared to the normal population (P=0.013), but our results do not show any impact on BMI, measured once in a cross-sectional study.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J, Dearnaley DP (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21: 1513–1523
Nord C, Fossa SD, Egeland T (2003) Excessive annual BMI increase after chemotherapy among young survivors of testicular cancer. Br J Cancer 88: 36–41
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Nord, C., Fosså, S. Reply: Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy. Br J Cancer 89, 1145 (2003). https://doi.org/10.1038/sj.bjc.6601179
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6601179